Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...

Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...

The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...

From soaring drug expenses in the Great Plains to rising supply costs in the West, regional disparities highlight the unique pressures facing hospital leaders. As labor shortages persist, supply ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

Nineteen companies, led by Pfizer, Johnson & Johnson, and UnitedHealth, accounted for 80% of payouts. Researchers suggest ...

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. Removing one time costs and benefits, earnings were $1.19 per share, easily ...

CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy benefits manager dealt with rising costs in its insurance division ...

The rising costs of prescription drug spend “The rising cost of healthcare particularly impacts self-insured employers and they’re looking for ways to pare down healthcare costs. Prescription ...

According to AAHC, the new fee would result in an estimated annual increase of $900 per person or $3,600 per family in ...